Epic Sciences Stock

epicsciences.comHealthcareFounded: 2008Funding to Date: $178.39MM

Epic Sciences is a developer of novel diagnostics designed to personalize and advance the treatment and management of cancer.

Register for Details

For more details on financing and valuation for Epic Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Epic Sciences.

Register Today


Management Team

Pascal Bamford Ph.D
Chief Scientific Officer and Head of Laboratory Operations
Dena Marrinucci Ph.D
Co-Founder & Member Clinical Advisory Board
Murali Prahalad Ph.D
Chief Executive Officer & President
Ryan Dittamore
Chief of Medical Innovation and Head of Translational Research Partnerships
Ian Miller JD
Chief Business Officer and General Counsel
Dave Henderson
Chief Information Officer

Board Members

Evgeny Zaytsev Ph.D
Kim Kamdar Ph.D
Domain Associates
John Sage
Andrew ElBardissi MD
Deerfield Management
Peter Kuhn Ph.D
Gregory Critchfield MD
Gregory Lucier
Simon Greenwood Ph.D
Roche Venture Fund

Other companies like Epic Sciences in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


Epic Sciences, a San Diego, CA-based developer of blood tests that predict therapeutic benefit for cancer patients, completed a $52m Series E financing